ACET Adicet Bio Inc

Price (delayed)

$9.52

Market cap

$89.12M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$10.46

Enterprise value

$65.98M

?
Relative Growth: Rel. Growth: 15
Relative Strength: Rel. Strength: 65
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 9

Adicet Bio, Inc. is a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. Adicet is advancing a pipeline of “off-the-shelf” ...

Highlights
ACET's EPS is up by 50% year-on-year and by 25% since the previous quarter
The company's net income rose by 17% YoY and by 9% QoQ
Adicet Bio's equity has decreased by 14% QoQ and by 10% YoY
The quick ratio has decreased by 12% from the previous quarter and by 10% YoY

Key stats

What are the main financial stats of ACET

ACET stock price

How has the Adicet Bio stock price performed over time
Intraday
-0.1%
1 week
-0.73%
1 month
15.67%
1 year
-32.53%
YTD
13.06%
QTD
10.19%

Financial performance

How have Adicet Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$103.71M
Net income
-$98.97M
Gross margin
N/A
Net margin
N/A
ACET's operating income is up by 18% YoY and by 9% from the previous quarter
The company's net income rose by 17% YoY and by 9% QoQ

Price vs fundamentals

How does ACET's price correlate with its fundamentals

Growth

What is Adicet Bio's growth rate over time

Valuation

What is Adicet Bio stock price valuation
P/E
N/A
P/B
0.74
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
ACET's EPS is up by 50% year-on-year and by 25% since the previous quarter
ACET's price to book (P/B) is 23% higher than its last 4 quarters average of 0.6 but 18% lower than its 5-year quarterly average of 0.9
Adicet Bio's equity has decreased by 14% QoQ and by 10% YoY

Efficiency

How efficient is Adicet Bio business performance
ACET's ROE is down by 9% YoY but it is up by 7% QoQ
Adicet Bio's return on assets has increased by 7% QoQ but it has decreased by 5% YoY
Adicet Bio's ROIC has increased by 6% from the previous quarter

Dividends

What is ACET's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ACET.

Financial health

How did Adicet Bio financials performed over time
The company's total assets fell by 13% QoQ and by 9% YoY
ACET's current ratio is down by 12% since the previous quarter and by 10% year-on-year
Adicet Bio's debt is 89% lower than its equity
Adicet Bio's debt has decreased by 16% YoY and by 8% QoQ
Adicet Bio's equity has decreased by 14% QoQ and by 10% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.